Anandamide, but not 2‐arachidonoylglycerol, accumulates during in vivo neurodegeneration
- 15 September 2001
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 78 (6), 1415-1427
- https://doi.org/10.1046/j.1471-4159.2001.00542.x
Abstract
Endogenous cannabinoid receptor ligands (endocannabinoids) may rescue neurons from glutamate excitotoxicity. As these substances also accumulate in cultured immature neurons following neuronal damage, elevated endocannabinoid concentrations may be interpreted as a putative neuroprotective response. However, it is not known how glutamatergic insults affect in vivo endocannabinoid homeostasis, i.e. N-arachidonoylethanolamine (anandamide) and 2-arachidonoylglycerol (2-AG), as well as other constituents of their lipid families, N-acylethanolamines (NAEs) and 2-monoacylglycerols (2-MAGs), respectively. Here we employed three in vivo neonatal rat models characterized by widespread neurodegeneration as a consequence of altered glutamatergic neurotransmission and assessed changes in endocannabinoid homeostasis. A 46-fold increase of cortical NAE concentrations (anandamide, 13-fold) was noted 24 h after intracerebral NMDA injection, while less severe insults triggered by mild concussive head trauma or NMDA receptor blockade produced a less pronounced NAE accumulation. By contrast, levels of 2-AG and other 2-MAGs were virtually unaffected by the insults employed, rendering it likely that key enzymes in biosynthetic pathways of the two different endocannabinoid structures are not equally associated to intracellular events that cause neuronal damage in vivo. Analysis of cannabinoid CB1 receptor mRNA expression and binding capacity revealed that cortical subfields exhibited an up-regulation of these parameters following mild concussive head trauma and exposure to NMDA receptor blockade. This may suggest that mild to moderate brain injury may trigger elevated endocannabinoid activity via concomitant increase of anandamide levels, but not 2-AG, and CB1 receptor density.Keywords
This publication has 51 references indexed in Scilit:
- Accumulation of the anandamide precursor and other N‐acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal deathJournal of Neurochemistry, 2001
- The Role of Excitotoxicity in Neurodegenerative DiseasePharmacology & Therapeutics, 1999
- Postnatal developmental changes in NSE and NNE mRNA expression in the rat pineal gland: In situ hybridization histochemistryJournal of Pineal Research, 1998
- Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and ratFEBS Letters, 1996
- Transacylase‐Mediated and Phosphodiesterase‐Mediated Synthesis of N‐Arachidonoylethanolamine, an Endogenous Cannabinoid‐Receptor Ligand, in Rat Brain MicrosomesEuropean Journal of Biochemistry, 1996
- Expression of the Neuron‐Specific Enolase Gene by Rat Oligodendroglial Cells During Their DifferentiationJournal of Neurochemistry, 1996
- Occurrence and postmortem generation of anandamide and other long‐chain N‐acylethanolamines in mammalian brainFEBS Letters, 1995
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Excitotoxic Brain Injury Suppresses Striatal High‐Affinity Glutamate Uptake in Perinatal RatsJournal of Neurochemistry, 1991
- N-Acylethanolamine phospholipid metabolism in normal and ischemic rat brainBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986